An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease
Top Cited Papers
- 12 August 2015
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 7 (300) , 300ra128
Abstract
A hydrogel binds to inflamed tissues, delivering therapeutics locally and reducing systemic drug exposure in mouse models of inflammatory bowel disease.Keywords
Funding Information
- NIH (CA112663, T32DK7191-38-S1, DE013023, EB000244, DE023432, AR063866)
- Alexander von Humboldt Foundation
- Harvard Institute of Translational Immunology/Helmsley Trust Pilot
This publication has 40 references indexed in Scilit:
- Enhanced Transferrin Receptor Expression by Proinflammatory Cytokines in Enterocytes as a Means for Local Delivery of Drugs to Inflamed Gut MucosaPLOS ONE, 2011
- On‐demand drug delivery from self‐assembled nanofibrous gels: A new approach for treatment of proteolytic diseaseJournal of Biomedical Materials Research Part A, 2011
- Orally delivered thioketal nanoparticles loaded with TNF-α–siRNA target inflammation and inhibit gene expression in the intestinesNature Materials, 2010
- Temporal and Spatial Analysis of Clinical and Molecular Parameters in Dextran Sodium Sulfate Induced ColitisPLOS ONE, 2009
- Nanoparticles Containing Anti-inflammatory Agents as Chemotherapy Adjuvants: Optimization and In Vitro CharacterizationThe AAPS Journal, 2008
- Communicable Ulcerative Colitis Induced by T-bet Deficiency in the Innate Immune SystemCell, 2007
- Local treatment of experimental colitis in the rat by negatively charged liposomes of catalase, TMN and SODJournal of Drug Targeting, 2006
- Enhanced adhesion of ligand‐conjugated biodegradable particles to colitic venulesThe FASEB Journal, 2005
- The Effect of Dexamethasone Treatment on Murine ColitisScandinavian Journal of Gastroenterology, 2000
- Macrophage Cultures: An Extracellular EsteraseScience, 1968